Markey John 13D/13G Filings for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Markey John 13D and 13G filings for Sonnet BioTherapeutics Holdings, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-08-07
07:00 am
Purchase
2023-08-0713GSonnet BioTherapeutics Holdings, Inc.
SONN
Markey John23,295
10.700%
2,273increase
(+10.81%)
Filing
2023-07-17
07:00 am
Purchase
2023-07-1713GSonnet BioTherapeutics Holdings, Inc.
SONN
Markey John21,023
11.100%
2,244increase
(+11.95%)
Filing
2023-07-07
07:00 am
Purchase
2023-07-0713GSonnet BioTherapeutics Holdings, Inc.
SONN
Markey John18,778
9.900%
2,699increase
(+16.78%)
Filing
2023-06-30
08:40 am
Purchase
2023-06-3013GSonnet BioTherapeutics Holdings, Inc.
SONN
Markey John16,080
8.500%
625increase
(+4.04%)
Filing
2023-06-12
10:39 am
Purchase
2023-06-1213GSonnet BioTherapeutics Holdings, Inc.
SONN
Markey John15,455
9.900%
2,386increase
(+18.26%)
Filing
2023-05-26
10:23 am
Purchase
2023-05-2513GSonnet BioTherapeutics Holdings, Inc.
SONN
Markey John13,068
8.400%
2,382increase
(+22.29%)
Filing
2023-05-17
3:49 pm
Purchase
2023-05-1713GSonnet BioTherapeutics Holdings, Inc.
SONN
Markey John10,687
6.850%
3,184increase
(+42.43%)
Filing
2023-05-01
9:49 pm
Purchase
2023-04-2813GSonnet BioTherapeutics Holdings, Inc.
SONN
Markey John7,503
6.500%
7,503increase
(New Position)
Filing